CA2425910A1 - Treatment and prevention of gastrointestinal disease using antagonists or partial agonists of 5ht1a receptors - Google Patents

Treatment and prevention of gastrointestinal disease using antagonists or partial agonists of 5ht1a receptors Download PDF

Info

Publication number
CA2425910A1
CA2425910A1 CA002425910A CA2425910A CA2425910A1 CA 2425910 A1 CA2425910 A1 CA 2425910A1 CA 002425910 A CA002425910 A CA 002425910A CA 2425910 A CA2425910 A CA 2425910A CA 2425910 A1 CA2425910 A1 CA 2425910A1
Authority
CA
Canada
Prior art keywords
pindolol
dyspepsia
treatment
receptors
gastrointestinal disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002425910A
Other languages
English (en)
French (fr)
Inventor
T. G. Dinan
P. W. N. Keeling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AGI Therapeutics Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/687,384 external-priority patent/US7098232B1/en
Application filed by Individual filed Critical Individual
Publication of CA2425910A1 publication Critical patent/CA2425910A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
CA002425910A 2000-10-13 2001-10-11 Treatment and prevention of gastrointestinal disease using antagonists or partial agonists of 5ht1a receptors Abandoned CA2425910A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/687,384 US7098232B1 (en) 1999-10-22 2000-10-13 Treatment and prevention of gastrointestinal disease using antagonists of partial agonists of 5HT1a receptors
US09/687,384 2000-10-13
PCT/IB2001/002759 WO2002030406A2 (en) 2000-10-13 2001-10-11 Use of antagonists or partial agonists of 5ht1a receptors for the preparation of a medicament for treatment and prevention of gastrointestinal diseases

Publications (1)

Publication Number Publication Date
CA2425910A1 true CA2425910A1 (en) 2002-04-18

Family

ID=24760250

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002425910A Abandoned CA2425910A1 (en) 2000-10-13 2001-10-11 Treatment and prevention of gastrointestinal disease using antagonists or partial agonists of 5ht1a receptors

Country Status (4)

Country Link
EP (1) EP1408937A2 (de)
JP (1) JP2004510814A (de)
CA (1) CA2425910A1 (de)
WO (1) WO2002030406A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101139744B1 (ko) * 2003-04-25 2012-04-26 미쓰비시 타나베 파마 코퍼레이션 알킬렌 디옥시벤젠 유도체 함유 경구 투여용 조성물
CA2557541C (en) * 2004-02-26 2014-12-16 Aska Pharmaceutical Co., Ltd. Pyrimidine derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO92436B1 (ro) * 1985-04-19 1987-10-01 Ioan Puscas Compozitie medicamentoasa sinergica pentru tratamentul gastritelor, gastroduodenitelor si ulcerelor gastroduodenale

Also Published As

Publication number Publication date
WO2002030406A2 (en) 2002-04-18
EP1408937A2 (de) 2004-04-21
WO2002030406A3 (en) 2004-02-12
JP2004510814A (ja) 2004-04-08

Similar Documents

Publication Publication Date Title
JP3712420B2 (ja) ５―ｈｔアゴニストの処方物
M Richey et al. Pharmacological advances in the treatment of insomnia
AU2003225837B2 (en) NE and 5-HT reuptake inhibitors for treating visceral pain syndromes
Srinivasan et al. Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics?
Wein Pharmacological agents for the treatment of urinary incontinence due to overactive bladder
Callahan Irritable bowel syndrome neuropharmacology: a review of approved and investigational compounds
MX2010005680A (es) Composiciones de tapentadol.
JPS61277620A (ja) 排尿困難治療剤
RU2007132852A (ru) Продукт комбинации о-десметилвенлафаксина и базедоксифена и его применение
Georgotas et al. Trazodone hydrochloride: A wide spectrum antidepressant with a unique pharmacological profile: A review of its neurochemical effects, pharmacology, clinical efficacy, and toxicology
JP2009539800A (ja) Ｃｇｒｐ拮抗薬による胃腸障害の治療
US6833383B2 (en) Methods for treating patients suffering from drug dependencies which lead to plasma melatonin deficiencies
NO327860B1 (no) Anvendelse av farmasoytiske kombinasjoner med tramadol for fremstilling av et legemiddel.
JP2011520952A (ja) 早漏治療用医薬組成物
US20060258732A1 (en) Treatment and prevention of gastrointestinal disease using antagonists or partial agonists of 5HT1a receptors
Camilleri Pharmacology and clinical experience with alosetron
CA2425910A1 (en) Treatment and prevention of gastrointestinal disease using antagonists or partial agonists of 5ht1a receptors
WO2004026296A1 (ja) 抗ストレス性疾患組成物
EP1815853B1 (de) Therapeutisches mittel ((-)-bpap) gegen drogenabhängigkeit
Scammell et al. Modafinil: a novel stimulant for the treatment of narcolepsy
Balfour et al. Venlafaxine extended-release: A review of its clinical potential in the management of generalised anxiety disorder
WO1997044045A1 (en) Malatonin in combination with analgesics
AU2011202540B2 (en) Methods of treatment using eszopiclone
CA2342341A1 (en) A new composition
CA2342223A1 (en) A new composition

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead